2-Azaspiro[3.4]octane Hydrochloride - CAS 1414885-15-6
Catalog: |
BB061230 |
Product Name: |
2-Azaspiro[3.4]octane Hydrochloride |
CAS: |
1414885-15-6 |
Synonyms: |
2-azaspiro[3.4]octane hydrochloride; 2-azaspiro[3.4]octane hcl; 2-azaspiro[3.4]octane; hydrochloride; 2-azaspiro[3.4]octanehydrochloride; 2-azaspiro[3,4]octane hydrochloride |
IUPAC Name: | 2-azaspiro[3.4]octanehydrochloride |
Description: | 2-Azaspiro[3.4]octane Hydrochloride is used as a reactant in the preparation of amines via titanium/polymethylhydrosiloxane-mediated reduction of nitriles. |
Molecular Weight: | 147.65 |
Molecular Formula: | C7H13N·HCl |
Canonical SMILES: | C1CCC2(C1)CNC2.Cl |
InChI: | InChI=1S/C7H13N.ClH/c1-2-4-7(3-1)5-8-6-7/h8H,1-6H21H |
InChI Key: | HGTKRTFHRJSJLP-UHFFFAOYSA-N |
References: | Laval, S., et al. Tetrahedron, 70, 975 (2014). |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
TW-202104236-A | New heterocyclic compounds | 20190409 |
AU-2013354114-B2 | Pyridine-2-amides useful as CB2 agonists | 20121207 |
CN-103748080-A | Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof | 20110526 |
CN-103748080-B | Quinazoline derivative species tyrosine kinase inhibitor and preparation method and application | 20110526 |
DK-2716633-T3 | QUINAZOLINE DERIVATIVE AS A TYROSIN-KINASE INHIBITOR, PROCEDURE FOR PREPARING IT AND USING THEREOF | 20110526 |
EP-2716633-A1 | Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof | 20110526 |
EP-2716633-B1 | Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof | 20110526 |
HU-E033575-T2 | Tyrosine kinase inhibitor quinazoline derivative, method of preparation and use | 20110526 |
JP-2014515358-A | Quinazoline derivatives as tyrosine kinase inhibitors, their preparation and use | 20110526 |
JP-5859118-B2 | Quinazoline derivatives as tyrosine kinase inhibitors, their preparation and use | 20110526 |
Complexity: | 86.6 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 2 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 147.0814771 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 147.0814771 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 12Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
-
[1866059-82-6]
1,1,2,2-Tetrafluoro-3-methylsulfonylpropane
-
[120739-62-0]
N-[(6-Chloropyridin-3-yl)methyl]-N-methylamine
-
[132182-92-4]
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
-
[30360-19-1]
N,N'-Diethyl-N''-isopropyl-1,3,5-triazine-2,4,6-triamine
-
[52236-30-3]
Metribuzin-desamino-diketo
-
[891016-02-7]
ML-SI3
INDUSTRY LEADERS TRUST OUR PRODUCTS